Product Images Topiramate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Topiramate NDC 68788-7351 by Preferred Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The text provides data on the cumulative rates for Time to First Seizure for two groups of patients, one treated with Topiramate 50mg/day and the other with Topiramate 400mg/day. The graph displays the results in terms of time (in days) and the proportion of patients experiencing a seizure, represented by the Y-axis. The statistical significance of the difference between the two treatments is denoted by P=0.0002.*
This is a chart that shows the change in the average monthly migraine period rate during a double-blind phase compared to baseline. The chart includes the results for a placebo group and three different groups receiving different doses of topiramate. The table also indicates that the results are statistically significant.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.